洁特生物：目前已进入德国、法国、英国等15个欧洲国家的科研机构和中小企业

Core Viewpoint - The company is experiencing steady growth in market penetration in Europe, leveraging competitive pricing and customizable services to enhance its brand presence in the region [1] Group 1: Market Expansion - The company has successfully entered 15 European countries, including Germany, France, and the UK, targeting research institutions and small to medium enterprises [1] - The overseas main business revenue is projected to reach 66.13% in 2024, indicating a significant shift towards international markets [1] Group 2: Business Strategy - The company maintains partnerships with international giants in the life sciences sector through an ODM business model [1] - The German subsidiary serves as a base for expanding the company's own brand promotion efforts, supported by sales teams located in Western Europe, the Middle East, South America, and Southeast Asia [1]